Lung fibrosis (WP3624)

Homo sapiens

Lung fibrosis pathway linked to events (molecular initiating event, key events and associative events) in a putative Adverse Outcome Pathway for lung fibrosis. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3624 CPTAC Assay Portal]

Authors

Friederike Ehrhart , Penny Nymark , Linda Rieswijk , Kristina Hanspers , Jonathan Mélius , Egon Willighagen , and Martina Summer-Kutmon

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Adverse Outcome Pathways Diseases Nanomaterials Pathways

Annotations

Disease Ontology

pulmonary fibrosis

Pathway Ontology

respiratory system disease pathway carbon nanotube response pathway

Participants

Label Type Compact URI Comment
ROSproduction Metabolite chebi:26523
ELMOD2 GeneProduct ensembl:ENSG00000179387
RTEL1 GeneProduct ensembl:ENSG00000258366
CXCL2 GeneProduct ensembl:ENSG00000081041
SPP1 GeneProduct ensembl:ENSG00000118785
DPP9 GeneProduct ensembl:ENSG00000142002
FGF1 GeneProduct ensembl:ENSG00000113578
CCL4 GeneProduct ensembl:ENSG00000275302
SMAD7 GeneProduct ensembl:ENSG00000101665
TERC GeneProduct ensembl:ENSG00000270141
CTGF GeneProduct ensembl:ENSG00000118523
SFTPA2 GeneProduct ensembl:ENSG00000185303
PARN GeneProduct ensembl:ENSG00000140694
CCL2 GeneProduct ensembl:ENSG00000108691
SERPINA1 GeneProduct ensembl:ENSG00000197249
SKIL GeneProduct ensembl:ENSG00000136603
TNF GeneProduct ensembl:ENSG00000232810
SFTPA1 GeneProduct ensembl:ENSG00000122852
IL6 GeneProduct ensembl:ENSG00000136244
EDN1 GeneProduct ensembl:ENSG00000078401
ELN GeneProduct ensembl:ENSG00000049540
CSF3 GeneProduct ensembl:ENSG00000108342
GREM1 GeneProduct ensembl:ENSG00000166923
DSP GeneProduct ensembl:ENSG00000096696
TERT GeneProduct ensembl:ENSG00000164362
MECP2 GeneProduct ensembl:ENSG00000169057
CXCL8 GeneProduct ensembl:ENSG00000169429
OBFC1 GeneProduct ensembl:ENSG00000107960
CALCA GeneProduct ensembl:ENSG00000110680
TGFA GeneProduct ensembl:ENSG00000163235
IL13 GeneProduct ensembl:ENSG00000169194
IL1B GeneProduct ensembl:ENSG00000125538
CCR3 GeneProduct ensembl:ENSG00000183625
CCL5 GeneProduct ensembl:ENSG00000271503
PDGFA GeneProduct ensembl:ENSG00000197461
CCL11 GeneProduct ensembl:ENSG00000172156
ATP11A GeneProduct ensembl:ENSG00000068650
FGF2 GeneProduct ensembl:ENSG00000138685
CMA1 GeneProduct ensembl:ENSG00000092009
IL5 GeneProduct ensembl:ENSG00000113525
EGF GeneProduct ensembl:ENSG00000138798
TIMP1 GeneProduct ensembl:ENSG00000102265
IL12B GeneProduct ensembl:ENSG00000113302
BMP7 GeneProduct ensembl:ENSG00000101144
PDGFB GeneProduct ensembl:ENSG00000100311
PTX3 GeneProduct ensembl:ENSG00000163661
NFE2L2 GeneProduct ensembl:ENSG00000116044
MMP9 GeneProduct ensembl:ENSG00000100985
FGF7 GeneProduct ensembl:ENSG00000140285
MUC5B GeneProduct ensembl:ENSG00000117983
CEBPB GeneProduct ensembl:ENSG00000172216
CYSLTR2 GeneProduct ensembl:ENSG00000152207
HMOX1 GeneProduct ensembl:ENSG00000100292
MMP2 GeneProduct ensembl:ENSG00000087245
HGF GeneProduct ensembl:ENSG00000019991
SFTPC GeneProduct ensembl:ENSG00000168484
CCR2 GeneProduct ensembl:ENSG00000121807
IL4 GeneProduct ensembl:ENSG00000113520
CSF2 GeneProduct ensembl:ENSG00000164400
PLAU GeneProduct ensembl:ENSG00000122861
FAM13A GeneProduct ensembl:ENSG00000138640
CCL3 GeneProduct ensembl:ENSG00000277632
MT2A GeneProduct ensembl:ENSG00000125148
IGF1 GeneProduct ensembl:ENSG00000017427
TGFB1 GeneProduct ensembl:ENSG00000105329

References

  1. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Muir H. Bioessays. 1995 Dec;17(12):1039–48. PubMed Europe PMC Scholia
  2. Mechanisms of actin stress fibre assembly. Naumanen P, Lappalainen P, Hotulainen P. J Microsc. 2008 Sep;231(3):446–54. PubMed Europe PMC Scholia
  3. Molecular and cellular mechanisms of pulmonary fibrosis. Todd NW, Luzina IG, Atamas SP. Fibrogenesis Tissue Repair. 2012 Jul 23;5(1):11. PubMed Europe PMC Scholia
  4. GeneMANIA: Fast gene network construction and function prediction for Cytoscape. Montojo J, Zuberi K, Rodriguez H, Bader GD, Morris Q. F1000Res. 2014 Jul 1;3:153. PubMed Europe PMC Scholia
  5. The Comparative Toxicogenomics Database’s 10th year anniversary: update 2015. Davis AP, Grondin CJ, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, et al. Nucleic Acids Res. 2015 Jan;43(Database issue):D914-20. PubMed Europe PMC Scholia
  6. Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP). Vietti G, Lison D, van den Brule S. Part Fibre Toxicol. 2016 Feb 29;13:11. PubMed Europe PMC Scholia
  7. Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes. Labib S, Williams A, Yauk CL, Nikota JK, Wallin H, Vogel U, et al. Part Fibre Toxicol. 2016 Mar 15;13:15. PubMed Europe PMC Scholia
  8. A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions. Nymark P, Rieswijk L, Ehrhart F, Jeliazkova N, Tsiliki G, Sarimveis H, et al. Toxicol Sci. 2018 Mar 1;162(1):264–75. PubMed Europe PMC Scholia